Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection

Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is the leading cause of pediatric viral respiratory tract infections. Neither vaccine nor effective antiviral therapy is available to prevent and treat RSV infection. Palivizumab, a humanized monoclonal antibody, is the only product approved to prevent serious RSV i...

Full description

Bibliographic Details
Main Authors: Sun, Zhiwu, Wang, Qian, Jia, Ran, Xia, Shuai, Li, Yuan, Liu, Qi, Xu, Wei, Xu, Jin, Du, Lanying, Lu, Lu, Jiang, Shibo
Format: Online
Language:English
Published: MDPI 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353917/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353917/

Similar Items